In the midst of an epidemic of prescription painkiller addiction and overdose deaths, a new Johns Hopkins Bloomberg School of Public Health survey suggests that more than half of patients prescribed opioids have leftover pills––and many save them to use later.

The first study of the microbiome––the community of microorganisms––in human breast ductal fluid has shown differences between the bacteria found in women who have experienced breast cancer and the bacteria present in those who have not.

Positive results have been reported from a phase 3 study of KIT-302 (Kitov Pharmaceuticals), a combination of the nonsteroidal anti-inflammatory drug (NSAID) celecoxib and the calcium channel blocker (CCB) amlodipine besylate.

Final results have been reported from a U.S. pivotal study of the EndoBarrier device (GI Dynamics, Inc.) in subjects with uncontrolled type-2 diabetes and obesity. The study was terminated early because of a higher-than-normal incidence of liver abscess, which can be fatal.

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has voted that live attenuated influenza vaccine (LAIV), also known as the “nasal spray” flu vaccine, should not be used during the 2016–2017 flu season.

Mobile phones are potential reservoirs of nosocomial bacteria and may pose an infection risk to patients if doctors and nurses don’t wash their hands after using them, according to a study published in Clinical Microbiology and Infection.

Nonmedical use of prescription opioids more than doubled among adults in the United States from 2001–2002 to 2012–2013, according to a study by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH).

The FDA has approved a supplemental new drug application to update the label for ceftazidime/avibactam (Avycaz, Allergan/AstraZeneca) with clinical data from a phase 3 trial that evaluated the treatment’s safety and efficacy in combination with metronidazole in patients with complicated intra-abdominal infections (cIAIs) caused by designated susceptible m

Six years after promising to “repeal and replace” the Patient Protection and Affordable Care Act (PPACA), House Republicans finally have a plan, according to an article posted on the Kaiser Health News website.

The Centers for Medicare and Medicaid Services (CMS) has released a summary of the findings from a validation pilot study of electronic clinical quality measures (eCQMs) conducted during the spring and summer of 2015.

The first patient has been vaccinated with an active tau vaccine, AADvac1 (Axon Neuroscience), in the phase 2 ADAMANT trial. AADvac1 was developed to be the first disease-modifying tau vaccine for patients with Alzheimer’s disease (AD) and other tauopathies.

In new study data, pitavastatin (Livalo, Kowa Pharmaceuticals America, Inc.) significantly reduced key arterial inflammation and immune-activation markers in patients with human immunodeficiency virus (HIV) infection receiving chronic antiretroviral therapy (ART) compared with pravastatin, a commonly prescribed statin for HIV-infected patients with dyslip

A three-year clinical study led by University of Florida Health researcher Kenneth Cusi, MD, has found that the diabetes treatment pioglitazone is safe and effective in certain patients who have nonalcoholic steatohepatitis (NASH), a chronic liver disease caused by a buildup of fat.

A growing number of employers are providing insurance coverage for telemedicine services that enable employees to connect with a doctor by phone using both voice and video. One limitation of these phone-based services, however, is that physicians can’t always obtain basic vital signs, such as blood pressure and heart rate.